Brainstorm Cell Therapeutics | BCLI - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Biogen USD 2.98B 1.02B 2026-06
Brainstorm Cell Therapeutics USD 2.05M 198K 2026-03
Cipla INR 62.31B 3.04B 2026-06
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 207.8M 7.22M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 193.34M 1.15M 2026-06
Mesoblast USD 82.31M 26.16M 2025-12